Chang Ki Hong
Overview
Explore the profile of Chang Ki Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
74
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Moon H, Park J, Kim N, Kim N, Park S, Kim Y, et al.
Neuro Oncol
. 2024 Oct;
27(3):841-853.
PMID: 39450860
Background: This study validates MRI-based tumor habitats in predicting time-to-progression (TTP), overall survival (OS), and progression sites in isocitrate dehydrogenase (IDH)-wildtype glioblastoma patients. Methods: Seventy-nine patients were prospectively enrolled between...
2.
Moon H, Park J, Kim N, Kim Y, Song S, Hong C, et al.
BMC Cancer
. 2024 Sep;
24(1):1197.
PMID: 39334005
Background: Physiologic MRI-based tumor habitat analysis has the potential to predict patient outcomes by identifying the spatiotemporal habitats of glioblastoma. This study aims to prospectively validate the cut-off for tumor...
3.
Lee C, Byeon Y, Kim G, Jeon J, Hong C, Kim J, et al.
Sci Rep
. 2024 Feb;
14(1):4615.
PMID: 38409363
Pleomorphic xanthoastrocytomas (PXA) are rare, accounting for < 1% of all astrocytomas. Literature on the clinical course and treatment outcomes of PXAs is limited. The study aimed to determine prognosis...
4.
Lee S, Park J, Park S, Kim Y, Hong C, Kim J, et al.
Korean J Radiol
. 2023 Jul;
24(8):772-783.
PMID: 37500578
Objective: Imaging-based survival stratification of patients with gliomas is important for their management, and the 2021 WHO classification system must be clinically tested. The aim of this study was to...
5.
Jeon H, Byun J, Kang H, Kim K, Lee E, Kim J, et al.
J Transl Med
. 2023 Feb;
21(1):69.
PMID: 36732815
Background: Recurrence is common in glioblastoma multiforme (GBM) because of the infiltrative, residual cells in the tumor margin. Standard therapy for GBM consists of surgical resection followed by chemotherapy and...
6.
Byun J, Song S, Kim Y, Hong C, Kim J, Kim J
World Neurosurg
. 2022 Dec;
171:e605-e610.
PMID: 36535554
Background: Brain metastasis from thyroid cancer (TCBM) is extremely rare; thus, despite a good treatment outcome for thyroid cancer, TCBM has shown poor clinical outcomes. Considering the short survival and...
7.
Byun J, Kim J, Kim M, Lee S, Kim Y, Hong C, et al.
Brain Tumor Res Treat
. 2022 Aug;
10(3):172-182.
PMID: 35929115
Background: There are numerous factors to consider in deciding whether to undergo surgical treatment for brain metastasis from lung cancer. Herein, we aimed to analyze the survival outcome and predictors...
8.
Hong C, Byun J, Park W, Kim Y, Park J, Ahn J, et al.
World Neurosurg
. 2022 Apr;
163:e230-e237.
PMID: 35364296
Objective: Internal carotid artery (ICA) injury during transsphenoidal surgery is a rare but serious complication. We analyzed a series of ICA injuries that occurred during a transsphenoidal approach to suggest...
9.
Byun J, Kim J, Song S, Kim Y, Hong C, Kim J
World Neurosurg
. 2022 Mar;
163:e207-e214.
PMID: 35342030
Background: The fate of residual tumor after salvage surgery for recurrent vestibular schwannoma (VS) after radiosurgery has not been elucidated so far. We reviewed our surgical series of salvage surgery...
10.
Byun J, Kim M, Song S, Kim Y, Hong C, Kim J
Brain Tumor Res Treat
. 2022 Feb;
10(1):22-28.
PMID: 35118844
Background: Extraventricular neurocytoma (EVN) is an extremely rare neuronal neoplasm that arises outside the ventricle. The clinical implication of the heterogenous prognosis of this rare tumor has not yet been...